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Background: Patients undergoing orthognathic procedures can require blood transfusions. The objectives of this
study were to evaluate the predictors of intra-operative blood loss in patients undergoing orthognathic procedures
and the transfusion rates and practices of our institution.
Materials and methods: This retrospective study included 92 patients who underwent the following four types of
orthognathic procedures: Group 1, bimaxillary; Group 2, bimaxillary with bone grafts; Group 3, LeFort I osteotomies;
and Group 4, LeFort I osteotomies with bone grafts. The intra-operative blood loss, operative time, age, gender and
pre- and post-operative HGB and HCT were assessed.
Results: The mean blood loss for all groups was 650 ± 397.8 mL, and there were differences in blood loss between
the four groups (p = 0.211). The mean operative time was 5 hours and 32 minutes. There were no differences in
intra-operative blood loss between the genders or the BMI categories. The operative time was moderately correlated
with the intra-operative blood loss (p < 0.001, r =0.332). Eighteen of the 92 patients (19.5%) received blood transfusions.
The mean intra-operative blood loss was higher among the patients who received transfusions (p < 0.001).
Conclusions: The only predictor of intra-operative blood loss was operative time. The observed transfusion rate was
higher than those that have been reported for similar procedures; thus, our institution needs to revisit our transfusion
policy and use more time-efficient techniques in the operating room.
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Orthognathic surgery for the correction of dento-facial
deformities is a well-established procedure. Due to the
high vascularity of the maxillofacial region, these proce-
dures result in blood loss that can require allogeneic
blood transfusions. There is an interest in the literature
in the amount of blood loss during these procedures and
the transfusion requirements of patients undergoing
bimaxillary procedures. The length of the surgery, the
experience of the surgeon, the gender of the patient [1]
and type of procedure [2] are all factors that have re-
ported to affect blood loss.
With the application of the many available techniques
for minimizing intraoperative blood loss, the requirementsCorrespondence: Moalsebaei@kau.edu.sa
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unless otherwise stated.of allogeneic blood transfusion have decreased in the past
decade [3].
The use of good operative techniques, knowledge of
the anatomy and the use of hypotensive anesthesia [4]
are well-documented methods for reducing blood loss.
The success of anti-fibrinolytic agents, such as tranex-
amic acid, in the reduction of intra-operative blood loss
has also been reported [5].
The transfusion requirements for a healthy patient
undergoing elective surgery do not depend on a single
criterion. Although transfusion triggers have been de-
fined in controlled trials as 7–8 g/dL [6], the decision
to transfuse depends on the perioperative vital signs,
hemoglobin concentration, patient co-morbidities and
good clinical judgment.
The aims of my study were to evaluate the predictors of
intra-operative blood loss and to assess the transfusion. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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our institution of the King AbdulAziz University Hospital,
Jeddah, Saudi Arabia.Materials and methods
This study was approved by the Unit of Biomedical
Ethics Research Committee, Faculty of Medicine, King
AbdulAziz University. A total of 100 consecutive pa-
tient records from 2009 to 2012 were retrospectively
analyzed. Eight of these records were excluded due to
incomplete data.Patients and procedures
A total of 92 patient records were included in the study.
All of the patients underwent either a single-piece
LeFort I osteotomy (LFI), a bilateral sagittal split osteot-
omy (BSSO) or a maxillary single-piece LFI bimaxillary
orthognathic surgery with or without an autogenous free
bone graft from a distant site (the anterior iliac crest or
cranial bone graft) at King AbdulAziz University Hospital.
The patients were grouped into four categories:
Group 1: bimaxillary surgery (LFI and BSSO), n = 42
Group 2: bimaxillary surgery (LFI and BSSO) with a
bone graft, n = 19
Group 3: maxillary surgery (LFI), n = 21
Group 4: maxillary surgery (LFI) with a bone graft, n = 10
Prior to the surgery, the American Society of Anesthe-
siologists status (ASA) was determined. Eighty-four of
the 92 (87%) patients were classified as ASA I, and 8/92
(13%) were classified as ASA II patients. None of the pa-
tients had cardiovascular, cerebrovascular, or coagulation
disorders or renal disease. All surgical procedures were
performed by one of two consultant oral and maxillo-
facial surgeons with one or more trainees from the inter-
mediate to senior level. The patients received 2 mg of
midazolam pre-operatively in the holding area, followed
by the induction of general anesthesia in the operating
room using the standard anesthesia protocol in our in-
stitution (propofol induction, sevoflurane inhalation and
muscle relaxant). An intravenous crystalloid solution
was administered to the patients at 0.5-1.0 mL/kg per
hour. The following hemodynamic parameters were used
to assess intravascular volumes status: heart rate, arterial
blood pressure, peripheral oxygen saturation, and urine
output. Hypotensive anesthesia was performed during
the maxillary component of the surgery. This anesthesia
achieved by decreasing the blood pressure to a mean of
50–60 mmHg via an increase in the inhaled anesthetic.
The estimated intra-operative blood loss was recorded
as per the protocol of our institution and was calculated
by subtracting the amount of irrigation fluid used fromthe amount of blood visible in the suction collection
canister.
Data
The following data were collected from the patients’ re-
cords: age, gender, weight, height, body mass index
(BMI), length of surgery, type of procedure, estimated
intra-operative blood loss (EBL), and pre- and post-
operative hemoglobin (HGB) and hematocrit (HCT).
The pre-operative HGB and HCT were collected from
the patient 1–2 days before the surgery, and the post-
operative HGB and HCT were collected 6–24 hours
after the surgery. The volume of intra-operative blood
loss was also evaluated according to the total length of
the surgery. The operative length was classified into the
following three categories: 1–3 hours, 3–6 hours, and 6–
10 hours. The individual cases that received packed red
blood cell (pRBC) transfusions and the lowest intra-
operative HGB values were recorded. The patients who
did and did not receive transfusions were further classified
according to the lowest intra-operative HGB for which a
value of 7 g/dL was used as a “transfusion trigger”.
Statistical analyses
The data were entered into a data entry sheet and de-
scriptive statistics were used to present the demograph-
ics and the pre-operative HGB and HCT data for both
the females and males.
The mean differences in age, BMI, intra-operative
blood loss (EBL), operative time, and pre- and postoper-
ative HGB and HCT were compared between the four
surgical groups using one-way ANOVAs with assumed
normal distributions. The relationship between operative
time and intra-operative blood loss was assessed using a
one-way ANOVA.
To evaluate whether intra-operative blood loss differed
based on the type of procedure, gender or BMI category,
one-way ANOVAs with assumed normal distributions
were performed. The correlations of the intra-operative
blood loss with the operative time, age and pre-operative
HGB were assessed using Pearson product–moment cor-
relation coefficients. A t-test was used to compare the EBLs
of the patients who underwent blood transfusions and
those of the patients who did not. A chi-square test was
used to compare the utilization of blood transfusions be-
tween patients with HGB values above and below 7 g/dL.
All statistical analyses were performed using SPSS, ver-
sion 20 (SPSS, Inc. IBM, Chicago, IL, USA). The level of
significance was set at p < 0.05.
Results
Demographic data and descriptive statistics
There were a total of 92 patients who underwent orthog-
nathic surgery for the correction of a dento-facial
Table 2 Mean pre-operative and post-operative
hemoglobin and hematocrit by gender
Gender N Mean SD Mean diff
Male Hemoglobin Pre 36 15.11 1.2 3.7
Post 36 11.44 2.3
Hematocrit Pre 36 44.26 3.7 10.2
Post 36 34.01 6.5
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whose mean age was 23.4 years, and 36 of the 92 patients
were males (39%) whose mean age was 22.6 years. The
mean age for both genders was 23 ± 6 years, and the mean
weight was 58.5 kg ± 12. The predominant BMI category
was normal (55/92 patients, 59.8%). The mean operative
time was 5 hours and 53 minutes (the range was 1:22 to
9:25). A summary of these data is presented in Table 1.Female Hemoglobin Pre 56 12.39 1.7 3.0
Post 56 9.39 1.7
Hematocrit Pre 56 37.20 4.2 8.9
Post 56 28.30 4.6Blood parameters
The mean pre-operative HGB for the females was 12.39 ±
1.7 g/dL, and this group exhibited a mean post-operative
drop of 3.0 g/dL. For the males, the mean pre-operative
HGB was 15.11 ± 1.2 g/dL, and the mean post-operative
drop was 3.7 g/dL as shown in Table 2.Blood loss
The mean intra-operative blood loss for all 92 patients
was 650 ± 397.8 mL with a range of 100 mL to 2500 mL.
The patients whose procedures lasted between 1–3
hours exhibited less intra-operative bleeding (p <0.001)
compared to the patients whose procedures lasted 3–6
hours or 6–10 hours. These data are shown in Table 3.Differences in the means between the surgical and
procedure groups
Neither age nor BMI were significantly different between
the four surgical groups (p = 0.120 and p = 0.705, respect-
ively). There were no differences in intra-operative blood
loss between the four surgical groups (p =0.211). The op-
erative time was significantly (p < 0.001) shorter for group
3 (LeFort I without a graft) as shown in Table 4.Table 1 Demographic data and descriptive statistics of
the patients included in the study
Demographics N %
Gender Male 36 39.1
Female 56 60.9
Total 92 100.0
BMI groups Underweight 17 18.5
Normal 55 59.8
Overweight or Obese 20 21.7
Total 92 100.0
Min Max Mean SD
Age 14 43 23.12 6.14
Height (cm) 145 187 163.34 8.7
Weight (kg) 38 95 58.58 12.23
BMI 14.87 32.11 21.85 3.62
Operative time (hrs:min) 1:13 9:15 5:32 1:52Predictors of blood loss
There were no differences in intra-operative blood loss,
age, or BMI category between the four surgical groups
(p = 0.211, p = 0.062 and p = 0.930, respectively; Table 5).
There was a moderate positive correlation between
intra-operative blood loss and operative time; the Pearson
correlation value was 0.33 (p <0.001) as shown in Table 6
and Figure 1. Weak positive correlations were found be-
tween the age of the patient and the pre-operative HGB
level and the intra-operative blood loss (r = 0.235 and
0.280, respectively).
Packed Red Blood Cell Transfusion
Overall, 18 of the 92 (19.5%) patients received a blood
transfusion. The mean EBL for the patients who received
a transfusion was 975 ± 548 ml, which was significantly
higher (p <0.001) than the mean EBL for those who did
not receive a transfusion (570 ml ± 308 ml). The distri-
butions of transfused patients for each of the surgical
groups are shown in Table 7.
A total of 21 units of packed red blood cells (pRBC)
were transfused, and one unit was used per patient with
the exception of one male patient who received 3 units
intra-operatively due to an active bleeding episode dur-
ing the maxillary surgery.
At the times at which the decisions for blood transfu-
sion were made decision for the 18 patients who re-
ceived transfusions, only 5 (27.8%) patients had reached
the lowest HGB value of 7 g/dL or less, and 13/18 pa-
tients (72.2%) were above 7 g/dL. One patient with aTable 3 Mean intra-operative blood loss and its
relationship to operative time
Length of surgery N Mean SD P-value
1-3 hrs. 15 316.67 206.73
>3-6 hrs. 36 713.89 435.17
>6-10 hrs. 41 715.85 359.94 0.001*
Total 92 650.00 397.80
*Significant using One-Way ANOVA at p < 0.05.
Table 4 Mean differences between the surgical groups, where: Group 1: Bimaxillary Surgery, Group 2: Bimaxillary with
bone graft, Group 3: Maxillary, Group 4: Maxillary with bone graft
Groups N Age BMI EBL Duration PreHGB PreHCT PostHGB PostHCT
Group 1 42 24.69 ± 6.2 21.70 ± 3.8 680.95 ± 313.12 5:58 ± 1:19 12.94 ± 2.0 38.51 ± 4.8 9.76 ± 2.1 29.42 ± 5.6
Group 2 19 22.79 ± 6.8 21.48 ± 3.0 744.74 ± 367 6:28 ± 1:07 14.14 ± 1.8 41.54 ± 4.8 9.82 ± 1.6 29.26 ± 4.2
Group 3 21 20.76 ± 5.3 22.61 ± 3.9 495.24 ± 517.91 3:25 ± 2:00* 13.64 ± 2.3 40.66 ± 6.7 11.25 ± 2.6 33.58 ± 7.7*
Group 4 10 22.10 ± 5.0 21.59 ± 3.8 665.00 ± 456.47 6:26 ± 1:11 13.97 ± 1.2 41.61 ± 3.5 10.53 ± 2.0 31.29 ± 5.4
Total 92 23.12 ± 6.1 21.85 ± 3.6 650.00 ± 397.8 5:32 ± 1:52 13.46 ± 2.0 39.96 ± 5.3 10.20 ± 2.2 30.54 ± 6.1
p-value 0.102 0.750 0.211 <0.001* 0.119 0.100 0.059 0.050*
Using one-way ANOVA test across the groups.
Where BMI = body mass index, EBL = estimated intra-operative blood loss, HGB = hemoglobin, HCT = hematocrit.
*Significant at p < 0.05.
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Figure 2.
Ten patients received intraoperative red blood cell
transfusions with a total of 14 units. All patients received
one unit each with the exception of one male patient
who received 3 units due to excessive bleeding from the
maxilla. The patient lost 2500 mL of blood, and his
HGB declined to 5.5 g/dL. This was the only patient
who exhibited class III hypovolemic shock, and he lost
an estimated 40% of his total blood volume.
Eight patients received postoperative blood transfu-
sions (24 to 48 hours after surgery), with a total of 8
units, and each of these patients received one unit. At
the time of transfusion, these patients vital signs were
consistent with class I hypovolemic shock.Cross-Match: Transfusion Ratio
The data were used to calculate the C: T ratio, which is
defined as the number of cross-matched units used
(perioperative and until hospital discharge) divided by
the number of cross-matched units requested. The total
of the cross-matched units 92, and the total number of
units utilized was 18. The cross-match/transfusion ratio
was 5.1:1.Table 5 Comparison of intra-operative blood loss relative
to procedure type, gender and BMI
One-way anova N Mean EBL SD p-value
Procedure
type
Group 1 42 680.95 313.1 0.211
Group 2 19 744.74 367
Group 3 21 495.24 517.9
Group 4 10 665.00 456.5
Gender Male 36 759.72 522.1 0.062
Female 56 579.46 274.6
BMI Underweight 17 617.65 301 0.930
Normal 55 654.55 421.2
Overweight or Obese 20 665.00 419.6
Total 92 650.00 397.8Discussion
Orthognathic procedures for the correction of dentofa-
cial deformities are complex surgical procedures for
which a considerable amount of blood loss is anticipated
due to the vascular natures of the maxillary and man-
dibular structures. Pre-operative assessments should aim
to evaluate ASA status and pre-operative HGB. The re-
ductions in HGB that were observed in both the males
and females in our study were greater than those that
have been reported in other studies [2,7]. Perez reported
that this reduction was not different between ASA I and
ASA II patients who exhibited reductions of 1.62 and
1.71, respectively [2]. In contrast, Fenner et al. reported
reductions of 3.4 among males and 3.2 among females,
but the mean pre-operative HGBs of the females (13.4)
and males (15.5) were higher [7].
The mean pre-operative HGB was within the normal
range for the females but was close to the lower end of
normal. According to the WHO classification, the cut-
offs for anemia are 12 g/dL for females and 13 g/dL for
males [8]. In Saudi Arabia, Alquaiz [9] found that 40%
of women of child bearing age suffered from anemia in
the city of Riyadh. These authors also found a mean
HGB of 12.35 (±1.80) g/dL. This parameter should be
taken considered when planning orthognathicTable 6 Correlation of intra-operative blood loss to
operative time, age and pre-operative hemoglobin level
Pearson correlation






Pre-operative hemoglobin r 0.280
p-value 0.007*
N 92
*Significant using Pearson’s Correlation Coefficient at p < 0.05.
Figure 1 A moderate correlation between intra-operative blood loss and operative time, using the Pearson Correlation Test, r- value
was 0.33 (p <0.001).
Al-Sebaei Patient Safety in Surgery 2014, 8:41 Page 5 of 8
http://www.pssjournal.com/content/8/1/41procedures, particularly procedures for females in our
society, by addressing low HGB levels with iron supple-
ments and/or referrals to a specialist prior to surgery for
optimization.
The study groups of the present study exhibited com-
parable ages and BMIs. Our results also indicated that
the amounts of blood lost did not differ between the
surgical sub-types (i.e., bimaxillary and maxillary and
with or without a graft), which might indicate that the
addition of another surgical site would not increase the
blood loss significantly. However, the mean EBL was
higher than those that have been reported in other
studies [2,10,11]. The mean EBL during orthognathicTable 7 Mean intra-operative blood loss (EBL) for
patients who underwent transfusion and those who did
not, and the distribution among the surgical groups
Blood transfusion N Mean EBL SD P value
Not transfused 74 570 308 <0.0001*
Transfused Group 1 11 813.63 342.11
Group 2 4 875 340
Group 3 2 1600 1275
Group 4 1 1900 0
Total transfused 18 975 548
*Significant using student’s t-test at p < 0.05.procedures using hypotensive anesthesia varies in the lit-
erature, and only one study has reported a range be-
tween 50 and 5000 mL [10]. Intraoperative blood loss in
orthognathic surgery was evaluated in a systematic re-
view by Pineiro-Aguilar et al. [3]. These authors found a
mean value of 436.11 ± 207.89 mL across a total of 17
studies that met the review criteria.
The predictors of intraoperative blood loss during
orthognathic procedures also vary in the literature. Some
authors have reported correlations with gender [1], op-
erative time [1,12] and surgeon experience [1].
Consistent with our findings, some studies have found
no significant predictors of EBL when examining factors
such as gender, preoperative blood ingredients [11], seg-
mentation of the maxilla, and Angle classification [13].
In general, the operative time did not vary with the
type of surgery with the exception of the maxillary sur-
gery without a graft (group 3) for which this time was
significantly shorter.
The average operating time in this study (the operative
time regardless of the addition of the bone graft proced-
ure) was 5 hours and 32 minutes (332 minutes), which is
higher than the previously reported times [7,11,14,15].
We also found a moderate correlation between EBL and
the duration of the operation, which is also consistent
with other studies [13,16].
Figure 2 The number of patients who underwent blood transfusion compared to those who did not, using a HGB of 7 g/dL as a
“transfusion trigger”. *Significant using Chi-Square test at p < 0.05.
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not a strong linear one; i.e., blood loss does not consist-
ently increase over time. The majority of intra-operative
blood loss is expected to occur in the beginning of the
procedure during the performance of the osteotomies.
Blood loss decreases as the multiple wounds are sutured.
Hour-by-hour records of EBL were not available in the
patients’ records.
The longer surgical time observed in this study could
be explained by several factors. First, the complexity of
the cases might have been responsible because patients
present with severe dento-facial deformities primarily
due to a lack of early intervention and access to health-
care and inter-family marriages. Second, our institution
is a training facility for oral and maxillofacial surgery
residents. A participating resident might be at an inter-
mediate or senior level without much experience in
orthognathic procedures, and time is required to allow
the resident to perform certain parts of the procedure
under direct supervision.
It is the policy of our institution that each patient pro-
vides two units of blood that can be donated by family
or friends prior to surgery. The rationale behind this
policy is to encourage the community to donate blood
products to the blood bank. Generally, our community
is not responsive to blood drives unless a relative is
undergoing surgery.It is also the policy of our hospital to cross-match one
unit of blood for orthognathic surgeries. In our study, 92
units were cross-matched, and only 21 of these units were
used. Thus, the match-to-transfusion ratio (C:T) was
5.1:1. According to the British Society of Hematology
(BSH), blood should not be available for surgery if the
usage is below 50%, which is equivalent to a C:T of 2:1
[17]. Any C:T above 2:1 indicates that units of blood need
to be ordered and reserved for the patient and not utilized.
In addition to the added cost that this limitation imposes
on the blood bank, it renders some units unavailable for
other patients who might need those units and decreases
the shelf-life of those particular units. Our institution
needs to revisit this cross-matching policy because it ap-
pears cross-matched units are being over-ordered.
The literature supports the notion that is there is no
need to cross-match units of pRBC for orthognathic
procedures [7,18,19] and that, even with reductions of
HGB and HCT, the bodies of in a hemodynamically
stable patients are able to compensate for the blood loss.
Many techniques to reduce blood loss in orthognathic
surgery have been described. The most established and
well documented of these techniques is hypotensive
anesthesia [3,11,15].
In a prospective, double blind, randomized, controlled
clinical study Ervens et al. found that hypotensive
anesthesia significantly reduced blood loss and minimized
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dilution [4].
Another widely used method is the peri-operative ad-
ministration of tranexamic acid which has been proven
to reduce intra-operative blood loss in bimaxillary proce-
dures in randomized clinical trials [5,20-22].
Blood transfusion is not without risks; this procedure
carries the risks of transfusion-transmissible infections
[23], immunological transfusion reactions and mis-
transfusions [24].
Autogenous blood is considered safer and to reduce
the risk of transfusion complications [25]; however,
many recent studies have not recommended the use of
autologous blood donation as a routine part of orthog-
nathic surgical procedures [7,12,18,19].
The reported transfusion rates for non-donor patients
undergoing orthognathic procedures using hypotensive
anesthesia over the last decade have been found to range
from 0% to 8% [4,7,26,27]. Our data revealed a rate of
blood transfusion (19.5%) that is higher than many of
the rates that have been reported for similar procedures
in the literature.
The criteria for transfusion for peri-operative patients
have been the subject of debate and study [6,17]. The
decision to transfuse patients undergoing orthognathic
procedures should rely on the following factors: (a) the
constant monitoring of blood loss with periodic assess-
ment of the surgical field to identify ongoing or active
bleeding; (b) monitoring of the intra-operative HGB (In
controlled trials, transfusion triggers have been defined
as 7–8 g/dL for healthy patients [6]);(c) monitoring for
the presence of inadequate perfusion and oxygenation of
the vital organs using dynamic parameters (i.e., blood
pressure, heart rate, temperature, oxygen saturation and
urine output; tachycardia, lactic acidosis, and increased
total body oxygen extraction (SvO2 < 65%) are consid-
ered to be “physiologic transfusion triggers” provided
that normovolemia and the proper depth of anesthesia
are maintained [28,29]); and (d) good communication
with the surgical team.
The intravascular status and any evidence of hypovol-
emia are evaluated during orthognathic surgeries using
hemodynamic parameters for which changes over time
are more significant than the actual measured levels.
Additionally, the use of an arterial line is a common
practice in our hospital during orthognathic cases; there-
fore, the anesthesiologist has access to the intraoperative
blood PH, arterial oxygen concentration and an accurate
HGB level.
The patients in our study were young, ASA I and ASA
II and had no histories of cardiac disease. These patients
had the physiologic reserves to compensate for the blood
loss provided that their HGB level was 7–8 and that they
were asymptomatic [6]. Few isolated cases of orthognathicprocedures are considered to be life-threatening [30], and
many of these have pre-existing coagulopathies that justify
the ordering of a cross-match or auto-donation [12,31].
The following questions remains. Is our institution
providing transfusions because they are readily available
and cross-matched? And does the hemodynamic status
of the patient justify the transfusion?
From a clinical standpoint and to minimize blood
transfusions in this patient population, the patients’ pre-
operative HGBs need to be optimized prior to the
orthognathic procedures. The vast majority of these pro-
cedures are elective and mean reductions of 3.0 g/dL
and 3.7 g/dL for the females and males, respectively,
were observed in our study. For females and males, min-
imums of 12 g/dL and 13 g/dL, respectively, should be
set as preoperative minimums for orthognathic proce-
dures. A referral to a specialist for correction of anemia
followed by subsequent testing should precede the sur-
gery. Furthermore, the use of adequate hypotensive
anesthesia during the osteotomy phase of the procedure
with a mean arterial blood pressure 30% below normal
(50–60 mmHg) has been proven to be valuable in redu-
cing intra-operative blood loss.Conclusions
The average intra-operative blood loss in our orthognathic
cases was higher than those that have been reported for
orthognathic cases and was moderately correlated with
operative time. The transfusion rate was high at 19.5%,
and 72.2% of those transfused patients received blood with
an HGB above 7 g/dL. Intra-operative blood loss was not
found to be correlated with the type of the procedure (i.e.,
maxillary or bimaxillary and with or without a bone graft),
BMI or gender.
With the exception of controlled arterial hypotension,
our institution does not follow any other procedures to
decrease intraoperative blood loss. Techniques such as
pre-operative autogenous blood donation and use of
tranexamic acid should be considered to minimize the
rate and risks of allogeneic blood transfusion. Further-
more, our hospital needs stricter transfusion criteria that
are based on the patient’s maximum allowable blood
loss, preoperative HGB and physiological reserve to
avoid inappropriate transfusion practices.Competing interests
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